Abstract
PURPOSE:The aim of this study was to determine the outcomes and timing within the product life cycle of all benefit-risk reassessment procedures for marketed products that were completed by the committee for medicinal product for human use during 2001-2012.METHODS:A cohort of all referral procedures for benefit-risk reassessment (Article 20, Article
... read more